Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
View Top Employees from Nektar TherapeuticsWebsite | http://www.nektar.com |
Ticker | NKTR |
Revenue | $103.1 million |
Funding | $2.1 billion |
Employees | 669 (669 on RocketReach) |
Founded | 1990 |
Address | 455 Mission Bay Boulevard South, San Francisco, California 94158, US |
Phone | (415) 482-5300 |
Fax | (650) 631-3150 |
Technologies |
JavaScript,
HTML,
PHP
+104 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Drug Development, Healthcare, Polymer Conjugate Chemistry |
Keywords | Biopharmaceuticals |
Competitors | Alkermes, Intarcia Therapeutics, Inc., MacroGenics, Inc., Neurocrine Biosciences, Sorrento Therapeutics, Inc. |
SIC | SIC Code 372 Companies, SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 37 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541712 Companies, NAICS Code 32 Companies, NAICS Code 541711 Companies, NAICS Code 325 Companies, NAICS Code 5417 Companies |
Looking for a particular Nektar Therapeutics employee's phone or email?
The Nektar Therapeutics annual revenue was $103.1 million in 2024.
Robert Bacci is the Senior Vice President, Human Resources and Facilities Operations of Nektar Therapeutics.
669 people are employed at Nektar Therapeutics.
Nektar Therapeutics is based in San Francisco, California.
The NAICS codes for Nektar Therapeutics are [54, 54171, 541, 541712, 32, 541711, 325, 5417].
The SIC codes for Nektar Therapeutics are [372, 28, 283, 37].